Literature DB >> 2786842

Inhibition of pregnancy viability in mice following IL-2 administration.

B U Tezabwala1, P M Johnson, R C Rees.   

Abstract

The influence of administration of interleukin-2 (IL-2) on syngeneic and allogeneic murine pregnancy has been investigated. Human or mouse recombinant IL-2 (rhIL-2 and rmIL-2), or partially purified rat IL-2, was inoculated i.p. into C57B1 mice following syngeneic mating but before embryo implantation. This inhibited subsequent fetal development in up to 100% of cases, compared with mice inoculated with control material, including recombinant human interleukin-1 alpha (IL-1 alpha), where no inhibition of pregnancy viability was observed. Similar data were obtained in both syngeneic and allogeneic matings when rhIL-2 was administered on Day 1 of pregnancy. Administration of rhIL-2 during the second pregnancy, rather than a first pregnancy, was less effective. Administration of rhIL-2 during the first pregnancy does not induce a permanent sterility. Histological examination of the endometrium further demonstrated that mice injected with rhIL-2 on Day 1 of their first pregnancy showed a complete absence of embryonic tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786842      PMCID: PMC1385298     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  The T-lymphocyte population in first-trimester human decidua does not express the interleukin-2 receptor.

Authors:  J N Bulmer; P M Johnson
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  Immunosuppressor factor(s) produced by decidua-associated suppressor cells: a proposed mechanism for fetal allograft survival.

Authors:  S Daya; K L Rosenthal; D A Clark
Journal:  Am J Obstet Gynecol       Date:  1987-02       Impact factor: 8.661

3.  Precursor phenotype of lymphokine-activated killer cells in the mouse.

Authors:  R R Salup; B J Mathieson; R H Wiltrout
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

4.  Human pregnancy serum inhibits interleukin-2 production.

Authors:  N S Nicholas; G S Panayi; A M Nouri
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

5.  Inhibition of interleukin-2 production by retroplacental sera: a possible mechanism for human fetal allograft survival.

Authors:  N S Nicholas; G S Panayi
Journal:  Am J Reprod Immunol Microbiol       Date:  1985-09

6.  Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

Authors:  B Combe; R M Pope; M Fischbach; B Darnell; S Baron; N Talal
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

7.  Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2.

Authors:  S E Ettinghausen; S A Rosenberg
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

8.  Suppression of mixed lymphocyte reaction by cells of human first trimester pregnancy endometrium.

Authors:  E Nakayama; S Asano; H Kodo; S Miwa
Journal:  J Reprod Immunol       Date:  1985-08       Impact factor: 4.054

9.  Diminished natural killer activity in pregnancy: modulation by interleukin 2 and interferon gamma.

Authors:  S Vaquer; A de la Hera; J Jordá; C Martínez; M Escudero; M Alvarez-Mon
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

10.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Authors:  S A Rosenberg; J J Mulé; P J Spiess; C M Reichert; S L Schwarz
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  12 in total

1.  Human amniotic fluid lacks interleukin-2 and interleukin-15 but can interact with the beta-chain of the interleukin-2 receptor.

Authors:  R F Searle; S J Bromage; J Palmer; J E Curry; A K Lang
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

2.  Increased expression of regeneration and tolerance factor in individuals with human immunodeficiency virus infection.

Authors:  B K DuChateau; G W Lee; M P Westerman; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

3.  Environmental levels of para-nonylphenol are able to affect cytokine secretion in human placenta.

Authors:  Nicoletta Bechi; Francesca Ietta; Roberta Romagnoli; Silke Jantra; Marco Cencini; Gianmichele Galassi; Tommaso Serchi; Ilaria Corsi; Silvano Focardi; Luana Paulesu
Journal:  Environ Health Perspect       Date:  2010-03       Impact factor: 9.031

4.  Upregulation of cytokines is detected in the placentas of cattle infected with Neospora caninum and is more marked early in gestation when fetal death is observed.

Authors:  Anne Rosbottom; E Helen Gibney; Catherine S Guy; Anja Kipar; Robert F Smith; Pete Kaiser; Alexander J Trees; Diana J L Williams
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

5.  Self-specific memory regulatory T cells protect embryos at implantation in mice.

Authors:  Ting Chen; Guillaume Darrasse-Jèze; Anne-Sophie Bergot; Tristan Courau; Guillaume Churlaud; Karina Valdivia; Jack L Strominger; Maria Grazia Ruocco; Gérard Chaouat; David Klatzmann
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

Review 6.  Cytokines: Important for implantation?

Authors:  Gérard Chaouat; Sylvie Dubanchet; Nathalie Ledée
Journal:  J Assist Reprod Genet       Date:  2007-11-28       Impact factor: 3.412

7.  Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2.

Authors:  Lynne Sykes; David A MacIntyre; Xiao J Yap; Sathana Ponnampalam; Tiong Ghee Teoh; Phillip R Bennett
Journal:  Mediators Inflamm       Date:  2012-05-29       Impact factor: 4.711

8.  Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion.

Authors:  S Vassiliadis; A Ranella; L Papadimitriou; A Makrygiannakis; I Athanassakis
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Comparison of fetal toxicity of various multi-wall carbon nanotubes in mice.

Authors:  Tomoko Fujitani; Akiko Inomata; Akio Ogata; Yoshimitsu Sakamoto; Akihiko Hirose; Tetsuji Nishimura; Reiko Ikeda; Dai Nakae
Journal:  Toxicol Rep       Date:  2015-07-19

Review 10.  Etiopathogenesis, Challenges and Remedies Associated With Female Genital Tuberculosis: Potential Role of Nuclear Receptors.

Authors:  Shalini Gupta; Pawan Gupta
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.